| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00198-004-1655-9 |
| P698 | PubMed publication ID | 15164161 |
| P2093 | author name string | Naoki Matsumoto | |
| Takami Miki | |||
| Yoshiki Nishizawa | |||
| Masaaki Inaba | |||
| Eiji Ishimura | |||
| Hiroshi Naka | |||
| Shuichi Jono | |||
| Takao Tsuchida | |||
| P2860 | cites work | A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group | Q29614889 |
| Circulating biochemical markers of bone remodeling in uremic patients | Q33650293 | ||
| Clinical utility of biochemical markers of bone remodeling | Q33701899 | ||
| Clinical use of biochemical markers of bone remodeling: current status and future directions | Q34029394 | ||
| Diagnosis of renal osteodystrophy: when and how to use biochemical markers and non-invasive methods; when bone biopsy is needed | Q34080037 | ||
| Different approaches to bone densitometry. | Q34118662 | ||
| Skeletal adaptations to alterations in weight-bearing activity: a comparison of models of disuse osteoporosis | Q34642153 | ||
| Renal osteodystrophy in chronic renal failure | Q34995768 | ||
| Pathophysiology and recent advances in the management of renal osteodystrophy | Q35018712 | ||
| Pathogenesis and treatment of renal osteodystrophy | Q35208020 | ||
| Predicting the failure load of the distal radius | Q39648564 | ||
| Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes | Q42481891 | ||
| Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients | Q44423486 | ||
| Cut-off values determined for vertebral fracture by peripheral quantitative computed tomography in Japanese women | Q44844671 | ||
| Tomographical description of tennis-loaded radius: reciprocal relation between bone size and volumetric BMD. | Q47267930 | ||
| Differential effects of menopause and metabolic disease on trabecular and cortical bone assessed by peripheral quantitative computed tomography (pQCT). | Q50657741 | ||
| Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis. | Q50697468 | ||
| Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients. | Q50707020 | ||
| The aminoterminal propeptide of type I procollagen: evaluation of a commercial radioimmunoassay kit and values in healthy subjects. | Q50970288 | ||
| A new serum assay to measure N-terminal fragment of telopeptide of type I collagen in patients with renal osteodystrophy. | Q51536030 | ||
| Measurement of plasma 1,25 dihydroxyvitamin D using a novel immunoextraction technique and immunoassay with iodine labelled vitamin D tracer. | Q52253508 | ||
| Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum | Q52325952 | ||
| Radius bone strength in bending, compression, and falling and its correlation with clinical densitometry at multiple sites. | Q53671981 | ||
| Maintenance of trabecular structure and bone volume by vitamin K(2) in mature rats with long-term tail suspension. | Q53676098 | ||
| Serum pyridinolines as specific markers of bone resorption in hemodialyzed patients | Q54179834 | ||
| Adynamic bone disease with negative aluminium staining in predialysis patients: prevalence and evolution after maintenance dialysis | Q57225919 | ||
| Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophy | Q70246530 | ||
| Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study | Q71163832 | ||
| Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients | Q71164117 | ||
| Studies on bone markers and bone mineral density in patients with chronic renal failure | Q71977938 | ||
| Bone mineral density evaluated by dual-energy X-ray absorptiometry after one-year treatment with calcitriol started in the predialysis phase of chronic renal failure | Q72302892 | ||
| Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease | Q72664908 | ||
| Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism | Q73234395 | ||
| Can novel clinical densitometric techniques replace or improve DXA in predicting bone strength in osteoporosis at the hip and other skeletal sites? | Q73359248 | ||
| Levels of serum and synovial fluid pyridinium crosslinks in patients with rheumatoid arthritis | Q73385955 | ||
| Comparison of the analytical and clinical performance characteristics of an N-MID versus an intact osteocalcin immunoradiometric assay | Q73571832 | ||
| Serum pyridinoline crosslinks as markers of tumour-induced bone resorption | Q73667083 | ||
| Rapid bone loss is associated with increased levels of biochemical markers | Q74293153 | ||
| Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture | Q74319377 | ||
| Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure | Q74459920 | ||
| A non-(1-84) circulating parathyroid hormone (PTH) fragment interferes significantly with intact PTH commercial assay measurements in uremic samples | Q74468883 | ||
| A structural approach to renal bone disease | Q77152829 | ||
| Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients | Q77373152 | ||
| Serum osteocalcin in relation to calcaneal bone mineral density in elderly men and women: a 5-year follow-up | Q77544132 | ||
| Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure | Q78197798 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteocalcin | Q59250722 |
| P304 | page(s) | 172-179 | |
| P577 | publication date | 2004-05-26 | |
| P1433 | published in | Osteoporosis International | Q7107640 |
| P1476 | title | The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure | |
| P478 | volume | 16 |
| Q50795081 | Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D. |
| Q53155783 | Bone microarchitecture is more severely affected in patients on hemodialysis than in those receiving peritoneal dialysis. |
| Q41625862 | Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study. |
| Q34069692 | Chronic kidney disease and bone fracture: a growing concern |
| Q35142758 | Discriminants of prevalent fractures in chronic kidney disease |
| Q55463750 | Matrix metalloproteinase-1 and -2 as markers of mineral bone disease in chronic kidney disease patients. |
| Q46285358 | Mineral and bone disorder is temporary in patients treated with early rapid corticosteroid reduction after kidney transplantation: a single-center experience |
| Q37038633 | Rapid cortical bone loss in patients with chronic kidney disease |
| Q91964524 | Serum sclerostin levels are positively related to bone mineral density in peritoneal dialysis patients: a cross-sectional study |
| Q39385131 | Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability |
Search more.